Obstructive Sleep Apnea (OSA) is a common and serious sleep disorder in which breathing is repeatedly interrupted during sleep. OSA occurs when the airway collapses as you breathe in. This can cause breathing to be paused from several seconds to over a minute. While many people use continuous positive airway pressure (CPAP) machines to manage their OSA, these systems can be cumbersome and awkward for some.
The Insomnia and Sleep Institute of Arizona is participating in a new research study for a product that may be able to help. The study is for an investigational oral medication for OSA taken nightly at bedtime.
If you qualify and choose to join the study, you will receive all study-related care and study medication at no cost and will also be compensated for your time and travel to attend study visits.
Study Description
The SynAIRgy Study is a randomized, double blind, placebo-controlled, 6-month parallel-arm study of AD109 vs placebo in participants with mild to severe OSA. The trial will enroll at least 640 participants in clinical centers across the United States and Canada.
To Participate in the Trial
Please use our contact form to let us know of your interest.
